Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients

Journal of Dermatology

Volumn 35, Issue 10, 2008, Pages 683-685

  Kashiwagi, Mariko ^a   Aihara, Michiko ^b   Takahashi, Yukitoshi ^c   Yamazaki, Etsuko ^c   Yamane, Yumiko ^b   Song, Yixuan ^a   Muramatsu, Masaaki ^a   Ikezawa, Zenro ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; LEUKOCYTE ANTIGEN;

CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DRESS SYNDROME; DRUG ERUPTION; DRUG RESPONSE; EPILEPSY; ERYTHEMA MULTIFORME; ERYTHRODERMA; GENE FREQUENCY; GENOTYPE; HLA SYSTEM; HLA TYPING; HUMAN; JAPANESE; LETTER; MACULOPAPULAR RASH; NEURALGIA; OBSESSIVE COMPULSIVE DISORDER; POLYMERASE CHAIN REACTION; STEVENS JOHNSON SYNDROME; STROKE;

CARBAMAZEPINE; DRUG ERUPTIONS; EPIDERMAL NECROLYSIS, TOXIC; GENE FREQUENCY; GENOTYPE; HLA-A ANTIGENS; HUMANS; STEVENS-JOHNSON SYNDROME;

EID: 54349111389     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2008.00548.x     Document Type: Letter

References (12)

1. Ferraro TN, Buono RJ. The relationship between pharmacology of antiepileptic drugs and human gene variation. Epilepsy Behav 2005 7 : 18 36.
2. Aihara Y, Ito SI, Kobayashi Y et al. Carmabazepine-induced hypersensitivity syndrome associated with transient hypogammmaglobulinemia and reactivation of human herpes 6 infection demonstrated by real-time quantitative polymerase chain reaction. Brit J Dermatol 2003 149 : 165 169.
3. Ranzey B, Correia O, Kelly JP et al. Risks of Stevens-Johnson Syndrome and Toxic epidermal necrosis during first weeks of antiepileptic therapy: a case-control study. Lancet 1999 353 : 2190 2194.
4. Rzany B, Mockenhuupt M, Baur S et al. Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson Syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry. J Clin Epidem 1996 49 : 769 773.
5. Chung WH, Hung SI, Hong HS et al. Medical genetics; a marker for Stevens-Johnson syndrome. Nature 2004 8 : 486.
6. Lonjou C, Thomas T, Borot N et al. A marker for Stevens-Johnson syndrome ethnicity matters. Pharmacogenomics J 2006 6 : 265 268.
7. Saito S, Ota S, Yamada E et al. Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population. Tissue Antigens 2000 56 : 522 529.
8. Alfirevic A, Jorgensen AL, Williamson PR et al. HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharamacogenomics 2006 7 : 813 818.
9. Man CB, Kwan P, Baum L et al. Association between HLA-B*1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese. Epilepsia 2007 48 : 1015 1018.
10. Hung SL, Chung WH, Jee SH et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions. Pharmacogenetics Genomics 2006 16 : 297 306.
11. Romphruk A, Phongaen K, Chotechai J et al. HLA-B*15 subtypes in the population of north-eastern Thailand. Eur J Immuno Genet 2003 30 : 153 158.
12. Ueta M, Sotozono C, Tokunaga K et al. Strong association between HLA-A*0206 and Stevens-Johnsons Syndrome in the Japanese. Am J Opthal 2007 143 : 367 368.